Capricorn Scientific and ExcellGene Form Strategic Partnership to Support Biotech Industries

This customer-oriented approach is dedicated to accelerating the biotech journey from R&D up to clinical production

29-Feb-2024 - Capricorn Scientific GmbH and ExcellGene SA have established a strategic partnership within the biotechnology sector. Applying their collective expertise and capabilities, the collaboration seeks to help customers by optimizing processes, developing products, and offering solutions in ...

Cytena Founds Subsidiary in Taiwan

24-Jul-2019 - Cytena is continuing its growth with the establishment of its subsidiary Cytena Bioprocess Solutions in Taiwan. Cytena Bioprocess Solutions is developing an innovative technology, which enables considerable reductions in time and increases in efficiency for cell line development. "With the new ...

Genedata Licenses its Bioprocess Software Platform to Sartorius Stedim Cellca

First-in-class enterprise workflow platform for streamlining cell line development operations

08-Nov-2018 - Genedata, a leading provider of advanced software solutions for biopharma R&D, today announced that Sartorius Stedim Cellca GmbH, a subsidiary of Sartorius Stedim Biotech (SSB) and a specialist for cell line development and bioanalytical services for large-scale protein production, has licensed ...

ProBioGen and Pionyr Immunotherapeutics initiate second collaboration

Collaboration in contract development and manufacturing

11-Jul-2018 - ProBioGen AG, a premier service and technology provider for complex therapeutic glycoproteins, andPionyr Immunotherapeutics, an immuno-oncology company which develops next generation antibody-based therapeutics that target the tumor microenvironment, today announced a second service and license ...

Subsidiary Heidelberg Pharma contracts Celonic

Contract contains antibody cell line development and antibody production

28-Sep-2016 - WILEX AG, announced that its subsidiary Heidelberg Pharma, has signed an agreement with Celonic AG, Basel, Switzerland, a specialist in the development and manufacturing of biologics (CDMO). This agreement includes cell line development and the production of non-GMP and GMP (Good Manufacturing ...

Celonic and IBI-Lorenzini announce a strategic collaboration

06-Sep-2016 - IBI-Lorenzini has entered into a partnership with the Swiss contract development and manufacturing organisation,Celonic, to establish high performance cell lines for R&D. Cell line development is one of the most challenging phases, especially when subsequent GMP compliance is required. To boost ...

Researchers develop novel cell line for screening of brain drugs

15-Jan-2016 - Researchers from the Department of Pharmacy at the University of Copenhagen have developed a cell line, which may be used to investigate new drugs and help predict whether they are able to enter the brain. The brain is protected by the so-called blood-brain barrier, a practically impermeable wall ...